Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes,Obesity and Lifestyle (AusDiab) Study

Abstract

Background

Framingham risk functions are widely used for prediction of future cardiovascular disease events. They do not, however, include anthropometric measures of overweight or obesity, now considered a major cardiovascular disease risk factor. We aimed to establish the most appropriate anthropometric index and its optimal cutoff point for use as an ancillary measure in clinical practice when identifying people with increased absolute cardiovascular risk estimates.

Design

Analysis of a population-based, cross-sectional survey was carried out.

Methods

The 1991 Framingham prediction equations were used to compute 5 and 10-year risks of cardiovascular or coronary heart disease in 7191 participants from the Australian Diabetes, Obesity and Lifestyle Study (1999-2000). Receiver operating characteristic curve analysis was used to compare measures of body mass index (BMI), waist circumference, and waist-to-hip ratio in identifying participants estimated to be at ‘high’, or at ‘intermediate or high’ absolute risk.

Results

After adjustment for BMI and age, waist-to-hip ratio showed stronger correlation with absolute risk estimates than waist circumference. The areas under the receiver operating characteristic curve for waist-to-hip ratio (0.67-0.70 in men, 0.64-0.74 in women) were greater than those for waist circumference (0.60-0.65, 0.59-0.71) or BMI (0.52-0.59, 0.53-0.66). The optimal cutoff points of BMI, waist circumference and waist-to-hip ratio to predict people at ‘high’, or at ‘intermediate or high’ absolute risk estimates were 26kg/m², 95 cm and 0.90 in men, and 25-26 kg/m², 80-85 cm and 0.80 in women, respectively.

Conclusions

Measurement of waist-to-hip ratio is more useful than BMI or waist circumference in the identification of individuals estimated to be at increased risk for future primary cardiovascular events. Eur J Cardiovasc Prev Rehabil 14: 740-745 © 2007 The European Society of Cardiology

Keywords

Keywords:adiposity anthropometry cardiovascular diseases risk assessment

Get full access to this article

View all access options for this article.

References

1 World Health Organization. The world health report 2004: changing history. Geneva, Switzerland: World Health Organization; 2004.

2 World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva 3-5 June 1997. Geneva, Switzerland: World Health Organization; 1998. (Publication no. WHO/NUT/NCD/98.1).

Stamler

Neaton

JD.

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153: 598–615.

Stamler

Wentworth

Neaton

JD.

Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823–2828.

5 Stratton

Adler

Neil

Matthews

Manley

Cull

, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–412.

6 Asia Pacific Cohort Studies Collaboration. Body mass index and cardiovascular disease in the Asia-Pacific region: an overview of 33 cohorts involving 310000 participants. Int J Epidemiol 2004; 33: 751–758.

Anderson

Odell

Wilson

Kannel

WB.

Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293–298.

Knuiman

HT.

Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health 1997; 51: 515–519.

Wilson

PWF

Evans

JC.

Coronary artery disease prediction. Am J Hypertens 1993; 6: S309–S313.

10.

10 Dunstan

Zimmet

Welborn

Cameron

Shaw

de Courten

, et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)- methods and response rates. Diabetes Res Clin Pract 2002; 57: 119–129.

11.

Haffner

Lehto

Ronnemaa

Pyorala

Laakso

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–234.

12.

12 Stevens

Kothari

Adler

Stratton

, United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671–679.

13.

13 World Health Organization Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva, Switzerland: World Health Organization; 1999. (Publication no. WHO/NCD/NCS/99.2).

14.

Rose

Blackburn

Cardiovascular surveymethods. Geneva, Switzerland: World Health Organization; 1968.

15.

Schisterman

Perkins

Liu

Bondell

Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology 2005; 16: 73–81.

16.

Calle

Thun

Petrelli

Rodriguez

Heath

Jr.

Body-mass index and mortality in a prospective cohort of US cohorts. N Engl J Med 1999; 341: 1097–1105.

17.

Welborn

Dhaliwal

Bennett

SA.

Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust 2003; 179: 580–585.

18.

Silventoinen

Jousilahti

Vartiainen

Tuomilehto

Appropriateness of anthropometric obesity indicators in assessment of coronary heart disease risk among Finnish men and women. Scand J Public Health 2003; 31: 283–290.

19.

Vague

The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20–34.

20.

20 Stolk

Suriyawongpaisal

Aekplakorn

Woodward

Neal

, InterASIA Collaborative Group Fat distribution is strongly associated with plasma glucose levels and diabetes in Thai adults: the InterASIA study. Diabetologia 2005; 48: 657–660.

21.

21 Reeder

Senthilselvan

Despres

Angel

Liu

Wang

, et al. The association of cardiovascular disease risk factors with abdominal obesity in Canada. CMAJ 1997; 157 (Suppl 1): S39–S45.

22.

22 Yusuf

Hawken

Ounpuu

Bautista

Franzosi

Commerford

, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640–1649.

23.

23 IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059–1062.